Aquestive Therapeutics, Inc.
AQST
$5.39
$0.316.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.86M | -8.06M | -31.86M | -15.45M | -13.55M |
| Total Depreciation and Amortization | 136.00K | 113.00K | 156.00K | 139.00K | 140.00K |
| Total Amortization of Deferred Charges | 1.77M | 2.29M | 2.75M | 2.75M | 2.75M |
| Total Other Non-Cash Items | 14.62M | 3.24M | 1.35M | 2.79M | 1.83M |
| Change in Net Operating Assets | -3.10M | -12.39M | 19.14M | -2.88M | 919.00K |
| Cash from Operations | -9.44M | -14.81M | -8.47M | -12.65M | -7.91M |
| Capital Expenditure | -212.00K | -52.00K | -85.00K | -235.00K | -107.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -212.00K | -52.00K | -85.00K | -235.00K | -107.00K |
| Total Debt Issued | 54.34M | -- | -- | -- | -- |
| Total Debt Repaid | -45.01M | -8.00K | -5.00K | -7.00K | -8.00K |
| Issuance of Common Stock | 680.00K | 4.76M | 683.00K | 81.49M | -- |
| Repurchase of Common Stock | -3.24M | -329.00K | -18.00K | -70.00K | -86.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.36M | -- | 0.00 | 0.00 | -6.00K |
| Cash from Financing | -2.59M | 4.42M | 660.00K | 81.41M | -100.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.24M | -10.44M | -7.89M | 68.53M | -8.12M |